Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Livzon Pharmaceutical Group

1985 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
000513 STOCK SYMBOL
1 INVESTMENTS
$5.33 SHARE PRICE (As of Thursday Closing)
Description

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises of western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drugs address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, as well as blood and hemopoietic system. The Company distributes its products within domestic market and to overseas markets.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Primary Office
  • No.132, Guihua Road North
  • Gongbei, Zhuhai
  • Guangdong, 519020
  • China

+86 175 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Livzon Pharmaceutical Group’s full profile, request a free trial.

Livzon Pharmaceutical Group Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.21 - $6.03 $4.37B $5.23 $0.18 12M 935M

Livzon Pharmaceutical Group Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,132,382 1,601,186 4,243,729 2,981,038
Revenue 1,354,526 1,339,423 1,262,360 1,148,772
EBITDA 197,956 236,025 894,515 206,066
Net Income 171,882 163,587 655,330 117,756
Total Assets 2,292,423 2,534,867 2,435,057 1,516,355
Total Debt 1,275 218,157 107 101
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Livzon Pharmaceutical Group Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 02-Oct-2019 00000 00000 00 000.00 Drug Delivery
To view this company’s complete investment and acquisition history, request access »